Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Jul 2017

Fourati Slim, Challine Dominique, Poveda Jean-Dominique, Laperche Syria, Rallier Sandrine, Pawlotsky Jean-Michel, Chevaliez Stéphane

Abstract excerpt

BACKGROUND: Detection and quantification of HBV DNA are essential to diagnose chronic HBV infection, monitor the virological response to treatment and the possible selection of resistant viruses in order to tailor therapy. The VERIS/MDx System HBV Assay is a random-access system that quantifies HBV DNA in clinical samples using unique single sample and reagent access during the workflow process without the need...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Viral
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B virus

Share to Limit of Detection

Share to Molecular Diagnostic Techniques

Share to Reagent Kits, Diagnostic

Share to Sensitivity and Specificity

Share to Viral Load

Source

Identifiers

PMID: 28549336
DOI: 10.1016/j.jcv.2017.05.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.PMID 28549336Read ↗

Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay.Semantic proximity Read ↗

A European multicenter study on the analytical performance of the VERIS HBV assay.Semantic proximity Read ↗

Performances of NeuMoDx, a random-access system for HBV-DNA and HCV-RNA quantificationSemantic proximity Read ↗

Analytical performance of the VERIS MDx system HCV assay for detecting and quantifying HCV RNA.Semantic proximity Read ↗

A cost-effective SYBR Green based Real-Time PCR platform for reliable detection of Hepatitis B Virus: Establishment and clinical validationSemantic proximity Read ↗

A real-time quantitative assay for hepatitis B DNA virus (HBV) developed to detect all HBV genotypes.Semantic proximity Read ↗

Comparison of the Abbott RealTime HBV assay with the Roche Cobas AmpliPrep/Cobas TaqMan HBV assay for HBV DNA detection and quantification.Semantic proximity Read ↗

Rapid, random-access, and quantification of hepatitis B virus using the Cepheid Xpert HBV viral load assay.Semantic proximity Read ↗

Comparison of the AdvanSure HBV real-time PCR test with three other HBV DNA quantification assays.Semantic proximity Read ↗

Clinical performance of the VERIS HCV assay for hepatitis C virus RNA quantification.Semantic proximity Read ↗

Performance of Version 2.0 of the Cobas AmpliPrep/Cobas TaqMan Real-Time PCR Assay for Hepatitis B Virus DNA QuantificationSemantic proximity Read ↗

A genotype-independent real-time PCR assay for quantification of hepatitis B virus DNA.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.